Northrop Grumman stock trades steadily as defense backlog and cash flow support valuation

Northrop Grumman stock is supported by a sizable defense order backlog and improved cash generation following the companys latest reported annual results for fiscal 2024, which showed higher sales and operating income compared with the prior year. In that period, Northrop Grumman reported total sales of about $40.0 billion, up from roughly $36.6 billion in fiscal 2023, highlighting mid single digit to high single digit growth across its major segments. The combination of sustained revenue growth, large multiyear contracts and disciplined capital allocation continues to underpin investor interest in the stock.

Revenue up from prior year

In its fiscal 2024 reporting, Northrop Grumman disclosed that total sales had increased to around $40.0 billion from approximately $36.6 billion in fiscal 2023, marking year over year growth of roughly 9%. The company attributed this expansion to stronger volumes in its Aeronautics Systems, Mission Systems, and Space Systems businesses, as well as progress on long term US Department of Defense programs. Revenue growth in the mid to high single digit range underlines the resilience of Northrop Grummans portfolio in an environment of elevated geopolitical tension and continued demand for advanced defense and space capabilities.

Operating income also improved in fiscal 2024, with Northrop Grumman reporting operating earnings of slightly more than $4.0 billion compared with approximately $3.8 billion in fiscal 2023. That increase of a few hundred million dollars reflects both higher sales and ongoing efforts to manage program costs and overhead, even as the company invests in next generation platforms. For investors, the combination of rising revenue and higher operating income suggests that the company has been able to balance growth with profitability.

Backlog above $70 billion

A key support for Northrop Grumman stock is the companys substantial backlog of contracted work, which provides multiyear visibility on future revenue. At the end of fiscal 2024, Northrop Grumman reported a total funded and unfunded backlog of more than $75 billion, compared with a backlog of around $70 billion at the end of fiscal 2023. This increase of roughly $5 billion year over year demonstrates that new awards and contract extensions continue to outpace deliveries, reinforcing the outlook for stable or growing sales in coming periods.

The backlog includes major long term programs such as the B-21 Raider bomber, classified space payloads, missile defense systems, and advanced communications and sensing solutions. Many of these programs are designed to run for a decade or more, and the associated backlog figures show how deeply Northrop Grumman is embedded in future US and allied defense planning. For shareholders, a backlog above $75 billion provides a buffer against short term budget fluctuations and offers a quantitative measure of the companys strategic positioning.

Free cash flow has also strengthened. In fiscal 2024, Northrop Grumman generated free cash flow of roughly $2.5 billion, compared with about $2.0 billion in fiscal 2023, representing an improvement of approximately $500 million. This additional cash supported a combination of dividends, share repurchases and debt reduction, while leaving room for continued investment in research and development. The rising free cash flow trend is an important factor for valuation, particularly for investors who monitor cash returns to shareholders.

B-21 and space systems drive growth

One representative product and program area for Northrop Grumman is the B-21 Raider, the next generation stealth bomber developed for the US Air Force. While detailed numbers are often classified, the company has indicated that work on the B-21 is contributing meaningfully to Aeronautics Systems revenue and backlog. In fiscal 2024, Northrop Grummans Aeronautics Systems segment recorded sales growth compared with fiscal 2023, supported in part by B-21 development and early production activities as well as ongoing support for existing platforms.

Space Systems is another engine of growth. In fiscal 2024, Northrop Grumman reported that Space Systems revenue had increased versus the prior year, driven by higher volumes in launch vehicles, space payloads, and mission support services. At a company level, the expansion in Space Systems has helped push overall sales toward the $40.0 billion mark, and the segment is expected to account for a growing share of total revenue over time. For investors monitoring long term trends, the combination of strategic bomber programs and space systems contracts illustrates how Northrop Grumman is positioned at the intersection of aerospace, defense and space.

Stock supported by defense exposure

Northrop Grumman stock is listed on the New York Stock Exchange under the ticker NOC. The company has often reported market capitalization in the tens of billions of dollars, reflecting investor recognition of its role as a major US defense and aerospace contractor. As of recent reporting dates, the market capitalization has typically been in a range around $60 billion, tracking changes in the share price and broader equity market conditions.

From a valuation perspective, investors frequently compare Northrop Grummans revenue and earnings growth, free cash flow and backlog metrics to those of peers in the US defense sector. With revenue at approximately $40.0 billion in fiscal 2024, operating income above $4.0 billion, free cash flow around $2.5 billion and a backlog exceeding $75 billion, the company presents a profile of steady growth, sizable contracted work and improving cash generation. These figures shape expectations for future dividends, share repurchases and investment capacity, and they help explain why Northrop Grumman stock remains a core holding in many defense oriented portfolios.

For shareholders and prospective investors, the key numbers to watch are the year over year changes in revenue, operating income, backlog and free cash flow. The roughly 9% increase in sales from about $36.6 billion in fiscal 2023 to around $40.0 billion in fiscal 2024, the incremental rise in operating income, the approximately $5 billion expansion in backlog and the $500 million uplift in free cash flow all point to a company that is growing while also strengthening its financial foundations. How these metrics evolve in coming years, especially as new programs such as the B-21 Raider transition from development to production, will be central to the ongoing assessment of Northrop Grumman stock.